Fredun Pharmaceuticals Limited
Fredun Pharmaceuticals Limited Share Price Chart
Fredun Pharmaceuticals Limited last traded at ₹1,510.75 (2026-10-13). Over the past month the stock moved +2.8%, three months the stock moved +103.2%, year the stock moved +268.8%. Its closing range over 52 weeks is ₹479.02 – ₹1,553.15, with the latest close 2.7% below the high.
Closing prices up to 2026-10-13.
About Fredun Pharmaceuticals Limited
Incorporated in 1987, Fredun Pharmaceuticals Ltd manufactures & exports healthcare and pharmaceuticals products[1]
Business Overview:{# https://www.bseindia.com/xml-data/corpfiling/AttachHis/2ad9e590-baf1-43e5-a921-d0d5a2e4d356.pdf#page=2#} The company is a diversified healthcare company engaged in pharmaceuticals, nutraceuticals, cosmeceuticals, dietary supplements, and animal healthcare products. Its pharmaceutical portfolio spans multiple therapeutic areas, including antihypertensives, antidiabetics, antiretrovirals (ARVs), and narcotics.
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Fredun Pharmaceuticals Limited reported sales of ₹228.00 crore (+90.0%) and net profit of ₹13.00 crore (+85.7%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 228.00 | 33.00 | 14.00 | 13.00 | 7.98 |
| Mar 2026 | 213.00 | 29.00 | 14.00 | 11.00 | 6.75 |
| Dec 2025 | 161.00 | 26.00 | 16.00 | 10.00 | 6.51 |
| Sep 2025 | 145.00 | 22.00 | 15.00 | 10.00 | 6.85 |
| Jun 2025 | 120.00 | 17.00 | 14.00 | 7.00 | 4.77 |
| Mar 2025 | 167.00 | 17.00 | 10.00 | 7.00 | 4.98 |
| Dec 2024 | 103.00 | 13.00 | 13.00 | 5.00 | 3.75 |
| Sep 2024 | 107.00 | 14.00 | 13.00 | 4.00 | 3.01 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +30.5% | +18.4% | +41.5% | +51.9% | +35.5% | +56.3% | +27.5% | +90.0% |
| Operating profit growth | +40.0% | +18.2% | +54.5% | +70.0% | +57.1% | +100.0% | +70.6% | +94.1% |
| Net profit growth | +0.0% | +25.0% | +40.0% | +75.0% | +150.0% | +100.0% | +57.1% | +85.7% |
| EPS growth | +7.9% | +25.4% | +38.7% | +63.9% | +127.6% | +73.6% | +35.5% | +67.3% |
| OPM % | 13.0% | 13.0% | 10.0% | 14.0% | 15.0% | 16.0% | 14.0% | 14.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Fredun Pharmaceuticals Limited reported sales of ₹639.00 crore (+40.1%) and net profit of ₹33.00 crore (+57.1%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 639.00 | 95.00 | 15.00 | 33.00 | 60.68 |
| Mar 2025 | 456.00 | 55.00 | 12.00 | 21.00 | 44.07 |
| Mar 2024 | 348.00 | 38.00 | 11.00 | 16.00 | 33.22 |
| Mar 2023 | 275.00 | 28.00 | 10.00 | 11.00 | 23.85 |
| Mar 2022 | 222.00 | 14.00 | 6.00 | 6.00 | 14.30 |
| Mar 2021 | 134.00 | 8.00 | 6.00 | 2.00 | 5.04 |
| Mar 2020 | 113.00 | 8.00 | 7.00 | 2.00 | 4.76 |
| Mar 2019 | 97.00 | 10.00 | 11.00 | 4.00 | 11.18 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +61.7% | +16.5% | +18.6% | +65.7% | +23.9% | +26.5% | +31.0% | +40.1% |
| Operating profit growth | +66.7% | -20.0% | +0.0% | +75.0% | +100.0% | +35.7% | +44.7% | +72.7% |
| Net profit growth | +100.0% | -50.0% | +0.0% | +200.0% | +83.3% | +45.5% | +31.3% | +57.1% |
| EPS growth | +118.8% | -57.4% | +5.9% | +183.7% | +66.8% | +39.3% | +32.7% | +37.7% |
| OPM % | 11.0% | 7.0% | 6.0% | 6.0% | 10.0% | 11.0% | 12.0% | 15.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Fredun Pharmaceuticals Limited.
Get Free AI Stock Analysis FREE →Latest News
-
Fredun Pharmaceuticals acquires 26% stake in Goodman Vetcare - Business Standard
-
Fredun Pharmaceuticals launches new platform 'PAWTALKS' for pet, animal healthcare
-
Fredun Pharmaceuticals gains on launching new platform 'PAWTALKS' for pet, animal healthcare
-
Fredun Pharmaceuticals surges after Q1 PAT rises 94% YoY to Rs 13 crore - Business Standard
-
Fredun Pharmaceuticals surges after Q1 PAT rises 94% YoY to Rs 13 crore - Business Standard
-
Fredun Pharmaceuticals consolidated net profit rises 79.67% in the March 2026 quarter - Business Standard
-
Fredun Pharmaceuticals moves up on launching cellular longevity dedicated platform ‘Daulcel’
-
Dr. Reddy's Laboratories, Fredun Pharmaceuticals and Lemon Tree Hotels to see some action today
Frequently Asked Questions
What is the share price of Fredun Pharmaceuticals Limited today?
Fredun Pharmaceuticals Limited shares were last quoted at ₹1,510.75 (-2.7% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Fredun Pharmaceuticals Limited?
Fredun Pharmaceuticals Limited has a price-to-earnings (P/E) ratio of 45.24 and a price-to-book (P/B) ratio of 7.15. The industry P/E is 53.33.
What is the 52-week high and low of Fredun Pharmaceuticals Limited?
The 52-week high of Fredun Pharmaceuticals Limited is ₹1,600.00 and the 52-week low is ₹427.00.
What is the market cap of Fredun Pharmaceuticals Limited?
The market capitalisation of Fredun Pharmaceuticals Limited is about ₹1,982.54 crore.
How did Fredun Pharmaceuticals Limited perform in its latest quarterly results?
In the latest quarter (Jun 2026), Fredun Pharmaceuticals Limited reported sales of ₹228.00 crore (+90.0%) and net profit of ₹13.00 crore (+85.7%), compared with the same quarter last year.
Is Fredun Pharmaceuticals Limited a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Fredun Pharmaceuticals Limited has a 3-year ROE of 15.00%, 3-year profit growth of 45.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Fredun Pharmaceuticals Limited?
Promoters hold about 44.57% of Fredun Pharmaceuticals Limited.
Which sector does Fredun Pharmaceuticals Limited belong to?
Fredun Pharmaceuticals Limited belongs to the Pharmaceuticals & Drugs sector.